Customs key to big-fish counterfeiters: 3M counsel

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Customs key to big-fish counterfeiters: 3M counsel

Sponsored by

incopro.png
sebastian-pena-lambarri-abj-zuko6mg-unsplash.jpg

Hosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021

The chief trademark counsel at 3M told an industry conference last month that brand owners must work closely with customs officials to reel in big-fish counterfeiters.

Colette Durst was speaking on a panel at Incopro’s Insync Virtual Summit on Thursday, January 28, alongside Jennifer Ehrlich, a strategic communications leader at 3M.

Durst, whom Managing IP also interviewed in late January, told the conference that brands should be prepared to do more with less in 2021 as budgets remain tight.

It came as a poll during the panel showed that nearly 50% of respondents have a smaller budget than at this time last year, while 34% said theirs had not changed. A further 19% said their budget has actually increased.

Durst and Ehrlich were reliving events from a year in which 3M’s workload has increased hugely. The company, which specialises in worker safety and healthcare, was put on the COVID frontline in early 2020 as demand for its N95 respirators soared.

At the same time, 3M witnessed a surge in trademark infringement, counterfeiting and fraud, particularly online. It responded by taking legal action and boosting communicating efforts, with 3M’s related in-house teams joining forces.

The IP team has also worked with law enforcement to stamp out counterfeiters, and Durst praised officials as “incredibly collaborative”. She said 3M will continue its work with the authorities, especially on large-sized cases.

3M has also used online and customs enforcement to make it harder for counterfeiters to get counterfeit respirators delivered to consumers. 

For the “big fish”, as she put it, Durst recommended using customs to block goods from entering a country and using the shipment data to track down the offenders. “That has been incredibly helpful,” she said.

Durst added that 3M is continuing to look at how else it can identify the big fish, including by using technology tools, even as the IP team does more with less in 2021.

For further examples of 3M’s communication efforts, please see: www.3m.com/covidfraud

To learn more about the panel, which was hosted by Managing IP’s managing editor Ed Conlon, please see the recording on the Insync website.

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article